A day (or two) with the Experts: the 2019 EU NanoString Summits Crosstalk
Since 2017 NanoString has hosted day-long summits in some of the liveliest and most charming European locations, where scientists and key opinion leaders have had the opportunity to share with their peers how NanoString Technologies has facilitated their breakthroughs, from...
Aiming at the Achilles’ heel of cancer: multiplexed lung cancer fusion detection without FISH or NGS
Lung cancer is the most commonly diagnosed cancer worldwide, and the leading cause of cancer deaths in the United States. It is generally divided into two types, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), based on...
Resolving the complexity of autoimmune diseases: challenges and solutions
Chronic inflammatory diseases are life-long debilitating illnesses with increased mortality and high healthcare costs for therapy and care. These are systemic conditions characterized by activation of either the adaptive immune system—rheumatoid arthritis, lupus, multiple sclerosis— or the innate immune system—Crohn’s...
miRNA Profiling in Malignant Melanoma: Making “Australia’s National Cancer” Obsolete.
Australia is a sun-worshipping country, the world capital for beautiful beaches, athletic surfers, cute marsupials, and the occasional weird-looking animal. But it is also the capital for something less pleasant: skin cancer. In fact, at least two in three Australians...
“In sickness and in health”: how individual immune response variability in health may influence how we respond to illness and therapy.
Thomas Fuller once said: "Health is not valued till sickness comes." Well, that may not be true anymore. It turns out that the key to successful disease management strategies may lie with a better understanding of individual immune response variabilities...